Our internal development program is focused on the development of nanoparticle based RNA therapeutics. To further explore the potential of our delivery technology 20Med is interested in discussing collaborations for other applications of our delivery platform. Strategic alliances are of interest based on access to 20Med's proprietary nanoparticle technology or co-development of RNA therapeutics. Read more about our innovative technology here.
Please contact us at BD@20medtx.com for any partnership inquiries or business opportunities.